Clinical Trial Update: Combination Disease-Modifying Antirheumatic Drugs (DMARDs) Versus Sulfasalazine in Inflammatory Back Pain [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial comparing combination disease-modifying antirheumatic drugs (DMARDs) versus sulfasalazine for inflammatory back pain in seronegative …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seronegative Spondyloarthropathies

Drugs mentioned

• Sulfasalazine (Sulfasalazine)

Snippet

Sponsor: Sanjay Gandhi Postgraduate Institute of Medical Sciences | Conditions: Seronegative Spondyloarthropathies | Phase 3 | Status: COMPLETED